V. Kaechele

Factors Affecting Liver Size

W. Kratzer, Violetta Fritz, R. Mason, 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Response to Reintroduction of Cetuximab in 5 Patients with Advanced, Chemotherapy-Resistant, Colorectal Cancer without Progressive Disease following First-Line Therapy with a Cetuximab-Containing Regimen

V. Kaechele, T. Seufferlein, G. Adler, 2008, Oncology.

Beneficial Treatment Management with Trifluridine/Tipiracil in a Patient with Metastatic Colorectal Cancer and Pronounced Hematological Event History during Previous Treatments

V. Kaechele, J. Hess, W. Schneider-Kappus, 2018, Case Reports in Oncology.

A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie

P. Galle, V. Kaechele, T. Seufferlein, 2010, Cancer Chemotherapy and Pharmacology.

Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease.

W. Kratzer, R. Mason, M. Haenle, 2005, World journal of gastroenterology.

[Intestinal wall vascularisation in Crohn's disease].

W. Kratzer, M. Haenle, V. Kaechele, 2004, Zeitschrift fur Gastroenterologie.

HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitors.

S. Rüdiger, C. Schumann, V. Kaechele, 2012, Pharmacogenomics.

Prevalence of Gallbladder Stone Disease in Obese Children and Adolescents: Influence of the Degree of Obesity, Sex, and Pubertal Development

W. Kratzer, M. Haenle, V. Kaechele, 2006, Journal of pediatric gastroenterology and nutrition.

Malignant extrarenal rhabdoid tumour (MERT) with liver metastases as a rare cause of an esophageal tumor in a 57 years old patient

V. Kaechele, T. Barth, W. Boeck, 2015, Zeitschrift für Gastroenterologie.

Ultrasonographically detected gallbladder polyps: A reason for concern? A seven-year follow-up study

W. Kratzer, R. Mason, M. Haenle, 2008, BMC gastroenterology.

Trastuzumab (TRA) in combination with different first-line chemotherapies for treatment of HER2-positive metastatic gastric or gastroesophageal junction cancer (MGC): Findings from the German noninterventional observational study HerMES.

V. Kaechele, S. Al-Batran, V. Petersen, 2012 .